Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Revitol Cellulite Cream

North Carolina State University And The University Of Strasbourg Agree To Collaborate On A Training Program
Strasbourg University and North Carolina State University, both leading academic institutions in the field of bioproduction, have entered into an agreement to collaborate on a unique set of training capabilities for industry. The Alsace Biovalley cluster has played and will continue to play a key role in the program by bringing together industry players in support of the project, ensuring that training programs meet industry needs, structuring the financial engineering required and securing funding for the infrastructures. Don't forget to buy zoloft online no prescription.

Predictors Of Patient Reported Outcomes And Cost Of Care In Younger Men With Newly Diagnosed Prostate Cancer
UroToday.com - In the online version of The Prostate, Dr. Ravishankar Jayadevappa and colleagues from the University of Pennsylvania analyzed the association between race, risk of biochemical recurrence and recovery pattern of patient reported outcomes such as satisfaction with care, HRQoL (generic and prostate-specific) and cost in younger men with newly diagnosed prostate cancer (CaP). The investigators hypothesized that younger African American men will have impaired HRQoL outcomes and will present with higher cost compared to younger Caucasian CaP patients.

generic viagra online


News of the day
ImmunoGen Announces Encouraging New Clinical Data With The Company's IMGN901 Compound In The Treatment Of Small-Cell Lung Cancer
ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops targeted anticancer therapeutics using its Targeted Antibody Payload (TAP) technology, today announced the presentation of encouraging initial efficacy, safety and tolerability clinical data with its IMGN901 product candidate in the treatment of small-cell lung cancer (SCLC). In two early-stage clinical trials that enrolled patients whose SCLC had recurred following treatment with standard chemotherapies, IMGN901 administration achieved notable tumor shrinkage and/or sustained stable disease. The compound also demonstrated encouraging activity against other CD56-expressing (CD56+) solid tumors. These clinical data are being presented at the 13th World Conference on Lung Cancer taking place in San Francisco, CA, from July 31 to Aug. 4, 2009.
Nutrition

Statements By Secretary Of Health And Human Services And Commissioner Of Food And Drugs, Regarding Passage Of The Family Smoking Prevention

Kathleen G. Sebelius: I am pleased Congress has taken swift action to pass the Family Smoking Prevention and Tobacco Control Act. The Food and Drug Administration (FDA) regulation of tobacco products will be a critical piece of a coordinated effort to save lives, lower costs and reduce suffering from heart disease, cancer and other tobacco-related illness. This is a great step towards a healthier America. Margaret A. Hamburg: The FDA welcomes the authority given to us by Congress to regulate tobacco products. Because smoking and chewing tobacco cause serious public health problems, we view our new responsibilities as a logical extension of our public health mission to protect and to advance the health of Americans. As we do with foods, drugs and medical products, the agency will rely on the best available science in fulfilling its regulatory responsibilities concerning tobacco. HHS


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009